Sage Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/12/2025

Shares

458,248

Value ($000)

4,179

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/12/2025	4,179	0.0%	458,248	6/30/2025
2025 Q1	9/15/2025	3,547	0.0%	446,178	3/31/2025
2024 Q4	2/6/2025	2,510	0.0%	462,309	12/31/2024
2024 Q3	11/12/2024	3,265	0.0%	452,193	9/30/2024
2024 Q2	8/12/2024	4,437	0.0%	408,576	6/30/2024
2024 Q1	5/9/2024	7,255	0.0%	387,139	3/31/2024
2023 Q4	2/6/2024	8,969	0.0%	413,905	12/31/2023
2023 Q3	11/8/2023	8,417	0.0%	408,987	9/30/2023
2023 Q2	8/10/2023	18,393	0.0%	391,168	6/30/2023
2023 Q1	5/12/2023	16,172	0.0%	385,417	3/31/2023
2022 Q4	2/13/2023	14,706	0.0%	385,576	12/31/2022
2022 Q3	11/14/2022	14,780	0.0%	377,415	9/30/2022
2022 Q2	8/15/2022	11,940	0.0%	369,650	6/30/2022
2022 Q1	5/13/2022	8,869	0.0%	267,945	3/31/2022
2021 Q4	2/11/2022	11,020	0.0%	259,034	12/31/2021
2021 Q3	11/16/2021	11,341	0.0%	255,933	9/30/2021
2021 Q2	8/16/2021	15,530	0.0%	273,355	6/30/2021
2021 Q1	5/17/2021	19,916	0.0%	266,072	3/31/2021
2020 Q4	2/16/2021	22,437	0.0%	259,349	12/31/2020
2020 Q3	11/13/2020	15,640	0.0%	255,889	9/30/2020
2020 Q2	8/20/2020	10,517	0.0%	252,916	6/30/2020
2020 Q1	5/15/2020	7,064	0.0%	245,934	3/31/2020
2019 Q4	2/7/2020	17,422	0.0%	241,330	12/31/2019